GMAB as reported
- Op Margin
- 25%
Op Margin · trailing twelve months to Q2 2024
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross Margin | 96% | n/a | Q2 2024 |
| Op Margin | 25% | n/a | Q2 2024 |
| Net Margin | 29% | n/a | Q2 2024 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Genmab A/S (GMAB) - Revenue & ProfitRevenue & ProfitGenmab A/S (GMAB)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com